首页> 外文OA文献 >A study of iopamidol (Iopamiron 370) in intravenous urography in the patients with previous adverse reactions to contrast media and history of allergy
【2h】

A study of iopamidol (Iopamiron 370) in intravenous urography in the patients with previous adverse reactions to contrast media and history of allergy

机译:碘帕醇(Iopamiron 370)在静脉尿路造影中对先前对造影剂和过敏史有不良反应的患者的研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Iopamidol (Iopamiron 370) was examined for use in intravenous urography in 37 patients who previously developed adverse reactions to conventional ionic contrast media or had a history of allergy. The patients were divided into three groups (group A1:22 patients with previous adverse reactions to contrast media, but without history of allergy, group A2:8 patients with previous adverse reactions to contrast media and with history of allergy, group B:7 patients with a history of allergy, but without experience of using contrast media. Adverse reactions to iopamidol were observed in 6 patients (one in group A1, four in group A2, one in group B) and there were no serious adverse reactions. In conclusion, iopamidol seems to be a safe contrast medium for the patients without history of allergy, but we should examine it carefully as in the case of conventional ionic contrast media.
机译:检查了37位先前对常规离子造影剂产生不良反应或有过敏史的患者中的碘帕醇(Iopamiron 370)用于静脉尿路造影。将患者分为三组(A1:22组以前对造影剂有不良反应但无过敏史,A2:8组以前对造影剂有不良反应并有过敏史,B组:7个病人具有过敏史,但没有使用造影剂的经验,在6例患者中观察到了对碘帕米多的不良反应(A1组1例,A2组4例,B组1例),并且没有严重的不良反应。对于没有过敏史的患者,碘帕醇似乎是一种安全的造影剂,但我们应像常规离子造影剂一样仔细检查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号